<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33810837</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0035-3787</ISSN><JournalIssue CitedMedium="Internet"><Volume>177</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>Revue neurologique</Title><ISOAbbreviation>Rev Neurol (Paris)</ISOAbbreviation></Journal><ArticleTitle>New advances in Amyotrophic Lateral Sclerosis genetics: Towards gene therapy opportunities for familial and young cases.</ArticleTitle><Pagination><StartPage>524</StartPage><EndPage>535</EndPage><MedlinePgn>524-535</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neurol.2021.01.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0035-3787(21)00456-2</ELocationID><Abstract><AbstractText>Due to novel gene therapy opportunities, genetic screening is no longer restricted to familial cases of ALS (FALS) cases but also aplies to the sporadic populations (SALS). Screening of four main genes (C9orf72, SOD1, TARDBP and FUS) identified the causes in 15% of Amyotrophic Lateral Sclerosis (ALS) patients (two third of the familial cases and 8% of the sporadic ones) but their respective contribution to ALS phenotype varies according the age of disease onset. The genetic overlap between ALS and other diseases is expanding and includes frontotemporal dementia, Paget's Disease of Bone, myopathy for adult cases, HSP and CMT for young cases highlighing the importance of retrieving the exhaustive familial history for each indivdual with ALS. Incomplete disease penetrance, diversity of the possible phenotypes, as well as the lack of confidence concerning the pathogenicity of most identified variants and/or possible oligogenic inheritance are burdens of ALS genetic counseling to be delivered to patients and at risk individuals. The multitude of rare ALS genetic causes identifed seems to converge to similar cellular pathways leading to inapropriate response to stress emphacising new potential therapeutic options for the disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amador</LastName><ForeName>M-D-M</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, 75013 Paris, France; D&#xe9;partement de Neurologie, Assistance Publique H&#xf4;pitaux de Paris (APHP), Centre de r&#xe9;f&#xe9;rence SLA &#xce;le de France, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, 75013 Paris, France. Electronic address: mariadelmar.amador@aphp.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muratet</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, 75013 Paris, France. Electronic address: francois.muratet@icm-institute.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teyssou</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, 75013 Paris, France. Electronic address: elisa.teyssou@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boill&#xe9;e</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, 75013 Paris, France. Electronic address: severine.boillee@sorbonne-universite.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Millecamps</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, 75013 Paris, France. Electronic address: stephanie.millecamps@icm-institute.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Rev Neurol (Paris)</MedlineTA><NlmUniqueID>2984779R</NlmUniqueID><ISSNLinking>0035-3787</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015316" MajorTopicYN="N">Genetic Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Inclusion body myopathy</Keyword><Keyword MajorTopicYN="N">Motor neuron diseases</Keyword><Keyword MajorTopicYN="N">Paget's disease of bone</Keyword><Keyword MajorTopicYN="N">Pathogenic mutation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>3</Day><Hour>5</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33810837</ArticleId><ArticleId IdType="doi">10.1016/j.neurol.2021.01.008</ArticleId><ArticleId IdType="pii">S0035-3787(21)00456-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>